[1]
D. Chung, D. Tung, and T. Dung, “Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit”, BMRAT, vol. 11, no. 4, pp. 6305-6325, Apr. 2024.